DK0807173T3 - Fremgangsmåder til fremstilling af immunoglobuliner indeholdende beskyttelsesproteiner i planter og anvendelse deraf - Google Patents

Fremgangsmåder til fremstilling af immunoglobuliner indeholdende beskyttelsesproteiner i planter og anvendelse deraf

Info

Publication number
DK0807173T3
DK0807173T3 DK95944237T DK95944237T DK0807173T3 DK 0807173 T3 DK0807173 T3 DK 0807173T3 DK 95944237 T DK95944237 T DK 95944237T DK 95944237 T DK95944237 T DK 95944237T DK 0807173 T3 DK0807173 T3 DK 0807173T3
Authority
DK
Denmark
Prior art keywords
immunoglobulins
plants
preparation
methods
pathogens
Prior art date
Application number
DK95944237T
Other languages
Danish (da)
English (en)
Inventor
Andrew C Hiatt
Julian K-C Ma
Thomas Lehner
Keith E Mostov
Original Assignee
Univ California
Planet Biotechnology Inc
King S College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/434,000 external-priority patent/US6046037A/en
Application filed by Univ California, Planet Biotechnology Inc, King S College London filed Critical Univ California
Application granted granted Critical
Publication of DK0807173T3 publication Critical patent/DK0807173T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
DK95944237T 1994-12-30 1995-12-27 Fremgangsmåder til fremstilling af immunoglobuliner indeholdende beskyttelsesproteiner i planter og anvendelse deraf DK0807173T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36739594A 1994-12-30 1994-12-30
US08/434,000 US6046037A (en) 1994-12-30 1995-05-04 Method for producing immunoglobulins containing protection proteins in plants and their use
PCT/US1995/016889 WO1996021012A1 (en) 1994-12-30 1995-12-27 Methods for producing immunoglobulins containing protection proteins in plants and their use

Publications (1)

Publication Number Publication Date
DK0807173T3 true DK0807173T3 (da) 2008-01-07

Family

ID=27003775

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95944237T DK0807173T3 (da) 1994-12-30 1995-12-27 Fremgangsmåder til fremstilling af immunoglobuliner indeholdende beskyttelsesproteiner i planter og anvendelse deraf

Country Status (11)

Country Link
US (2) US6303341B1 (ja)
EP (2) EP0807173B1 (ja)
JP (1) JPH11504901A (ja)
CN (1) CN1183802A (ja)
AT (1) ATE369423T1 (ja)
AU (1) AU722668B2 (ja)
CA (1) CA2208783C (ja)
DE (1) DE69535557T2 (ja)
DK (1) DK0807173T3 (ja)
ES (1) ES2292173T3 (ja)
WO (1) WO1996021012A1 (ja)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7005560B1 (en) * 1989-10-27 2006-02-28 The Scripps Research Institute Transgenic plants expressing assembled secretory antibodies
US5959177A (en) * 1989-10-27 1999-09-28 The Scripps Research Institute Transgenic plants expressing assembled secretory antibodies
US6808709B1 (en) 1994-12-30 2004-10-26 The Regents Of The University Of California Immunoglobulins containing protection proteins and their use
US5990385A (en) * 1997-11-10 1999-11-23 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture And Agri-Food Protein production in transgenic alfalfa plants
WO1999049024A2 (en) * 1998-03-25 1999-09-30 Planet Biotechnology, Inc. Methods and compositions for production of multimeric proteins in transgenic plants
US7485715B2 (en) * 1999-06-18 2009-02-03 Ceres, Inc. Sequence-determined DNA encoding AP2 domain polypeptides
US7479555B2 (en) * 1999-07-21 2009-01-20 Ceres, Inc. Polynucleotides having a nucleotide sequence that encodes a polypeptide having MOV34 family activity
IL151972A0 (en) * 2000-03-27 2003-04-10 Univ California Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof
US20060015969A1 (en) * 2000-04-28 2006-01-19 Planet Biotechnology, Inc. Novel immunoadhesins for treating and prventing toxicity and pathogen-mediated diseases
EP1290027B1 (en) 2000-04-28 2009-09-09 Planet Biotechnology, Inc. Immunoadhesin for the prevention of rhinovirus infection
US7304208B2 (en) * 2000-05-02 2007-12-04 Ventria Bioscience Expression of human serum albumin (HSA) in monocot seeds
US6696620B2 (en) * 2000-05-02 2004-02-24 Epicyte Pharmaceutical, Inc. Immunoglobulin binding protein arrays in eukaryotic cells
JP2004506695A (ja) * 2000-08-24 2004-03-04 ワシントン　デンタル　サービス う蝕の予防の免疫学的方法
WO2002102979A2 (en) * 2001-06-15 2002-12-27 UNIVERSITY OF TOLEDO, THE a University instrumentality of the State of Ohio Transformation of mono- and di- cotyledonous plants
US20070118934A1 (en) * 2001-10-26 2007-05-24 Planet Biotechnology, Inc. Chimeric toxin receptor proteins and chimeric toxin receptor proteins for treatment and prevention of anthrax
USRE47770E1 (en) 2002-07-18 2019-12-17 Merus N.V. Recombinant production of mixtures of antibodies
ATE514717T1 (de) * 2002-07-18 2011-07-15 Merus B V Rekombinante produktion von antikörpermischungen
US7476777B2 (en) * 2002-09-17 2009-01-13 Ceres, Inc. Biological containment system
WO2004027038A2 (en) * 2002-09-17 2004-04-01 Ceres, Inc. Biological containment system
WO2004106375A1 (en) 2003-05-30 2004-12-09 Merus Biopharmaceuticals B.V. I.O. Fab library for the preparation of anti vegf and anti rabies virus fabs
US20100069614A1 (en) 2008-06-27 2010-03-18 Merus B.V. Antibody producing non-human mammals
US20050138692A1 (en) * 2003-06-02 2005-06-23 Biotechnology Foundation, Inc. Production of cancer-specific antibodies in plants
JP2007517504A (ja) * 2003-12-09 2007-07-05 ベントリア バイオサイエンス 融合担体として種子貯蔵蛋白を利用する植物種子中の融合ポリペプチドの高水準発現
CA2551392A1 (en) * 2003-12-23 2005-07-28 Ventria Bioscience Methods of expressing heterologous protein in plant seeds using monocot non seed-storage protein promoters
CA2554054C (en) 2004-01-20 2013-06-04 Merus B.V. Mixtures of binding proteins
US9758790B2 (en) 2004-12-08 2017-09-12 Ceres, Inc. Modulating the level of components within plants
WO2007050625A1 (en) * 2005-10-25 2007-05-03 Ceres, Inc. Modulation of triterpenoid content in plants
AU2006216715A1 (en) * 2005-02-22 2006-08-31 Ceres Inc. Modulating plant alkaloids
US7312376B2 (en) * 2005-04-20 2007-12-25 Ceres, Inc. Regulatory regions from Papaveraceae
US8124839B2 (en) * 2005-06-08 2012-02-28 Ceres, Inc. Identification of terpenoid-biosynthesis related regulatory protein-regulatory region associations
ES2426194T3 (es) * 2005-08-02 2013-10-21 Planet Biotechnology, Inc. Proteínas quiméricas del receptor de toxina mejoradas y proteínas quiméricas del receptor de toxina para el tratamiento y la prevención de anthrax
US20100062137A1 (en) * 2005-09-30 2010-03-11 Steven Craig Bobzin Modulating plant tocopherol levels
US20070199090A1 (en) * 2006-02-22 2007-08-23 Nestor Apuya Modulating alkaloid biosynthesis
WO2007117693A2 (en) * 2006-04-07 2007-10-18 Ceres, Inc. Regulatory protein-regulatory region associations related to alkaloid biosynthesis
US8470308B2 (en) * 2009-01-03 2013-06-25 Ray C. Wasielewski Enhanced medical implant comprising disrupted tooth pulp and tooth particles
US10328103B2 (en) 2009-01-03 2019-06-25 Ray C. Wasielewski Medical treatment composition comprising mammalian dental pulp stem cells
PT2838917T (pt) 2012-04-20 2019-09-12 Merus Nv Métodos e meios para a produção de moléculas similares a ig heterodiméricas
PL2888283T3 (pl) 2012-08-24 2019-03-29 The Regents Of The University Of California Przeciwciała i szczepionki do stosowania w leczeniu nowotworów z ekspresją ROR1 i w hamowaniu przerzutu
EP2762496A1 (en) 2013-02-05 2014-08-06 EngMab AG Method for the selection of antibodies against BCMA
WO2014122143A1 (en) 2013-02-05 2014-08-14 Engmab Ag Method for the selection of antibodies against bcma
WO2014124457A1 (en) * 2013-02-11 2014-08-14 University Of Louisville Research Foundation, Inc. Methods for producing antibodies
EP2789630A1 (en) 2013-04-09 2014-10-15 EngMab AG Bispecific antibodies against CD3e and ROR1
CA2963692A1 (en) 2014-10-09 2016-04-14 Engmab Ag Bispecific antibodies against cd3epsilon and ror1
EA202092435A3 (ru) 2015-08-03 2021-06-30 Энгмаб Сарл Моноклональные антитела против bcma
US10688181B2 (en) 2016-06-27 2020-06-23 The Regents Of The University Of California Cancer treatment combinations
WO2018083204A1 (en) 2016-11-02 2018-05-11 Engmab Sàrl Bispecific antibody against bcma and cd3 and an immunological drug for combined use in treating multiple myeloma
JP2021536489A (ja) * 2018-09-05 2021-12-27 ベントリア、バイオサイエンス、インコーポレイテッドVentria Bioscience Inc. 免疫グロブリンａ製剤
US12016885B2 (en) 2018-11-06 2024-06-25 Alsatech, Inc. Method of solubilizing TDP-43 protein aggregates in amyotrophic lateral sclerosis using a microvascular endothelial cell expressing an anti-TDP-43 Fab
CN113875778A (zh) * 2021-09-29 2022-01-04 季红进 含有植物免疫活性蛋白和5-氨基乙酰丙酸或其衍生物的生物刺激剂

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873191A (en) 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US4443549A (en) 1981-10-19 1984-04-17 Molecular Genetics, Inc. Production of monoclonal antibodies against bacterial adhesins
US4652448A (en) 1982-10-07 1987-03-24 Molecular Genetics, Inc. Use of monoclonal antibodies against bacterial adhesins
US4870009A (en) 1982-11-22 1989-09-26 The Salk Institute For Biological Studies Method of obtaining gene product through the generation of transgenic animals
US5034322A (en) 1983-01-17 1991-07-23 Monsanto Company Chimeric genes suitable for expression in plant cells
US5352605A (en) 1983-01-17 1994-10-04 Monsanto Company Chimeric genes for transforming plant cells using viral promoters
GB8303994D0 (en) 1983-02-14 1983-03-16 Council Of Governors Of United Antigenic materials
FI68590C (fi) 1984-03-15 1985-10-10 Rosenlew Ab Oy W Flexibel behaollare foer transport och lagring av massagods
US4736866B1 (en) 1984-06-22 1988-04-12 Transgenic non-human mammals
WO1987000551A1 (en) 1985-07-16 1987-01-29 The Salk Institute For Biological Studies Genetic alteration of plants with retroviruses
CA1313830C (en) 1985-08-07 1993-02-23 Dilip Maganlal Shah Glyphosate-resistant plants
US5352446A (en) 1986-03-25 1994-10-04 Council Of Governors Of The United Medical And Dental Schools Of Guy's And St. Thomas's Hospitals Method of treating dental caries with monoclonal antibodies against the antigen I and antigen I/II of streptococcus mutans
GB8704648D0 (en) 1987-02-27 1987-04-01 Guy S & St Thomas S Hospitals Antibodies
US5352440A (en) 1988-03-30 1994-10-04 Trustees Of Boston University Methods for increasing melanin content in melanocytes using diacylglycerols and uses thereof
DE68923728T2 (de) 1988-04-25 1996-02-22 Monsanto Co Insektenresistente Salatpflanzen.
US5183756A (en) 1988-08-19 1993-02-02 The United States Of America As Represented By The Department Of Health And Human Services Monoclonal antibody (D612) having selective reactivity for gastrointestinal caricinomas and method for employing the same
CA2016842A1 (en) 1989-05-16 1990-11-16 Richard A. Lerner Method for tapping the immunological repertoire
US5959177A (en) 1989-10-27 1999-09-28 The Scripps Research Institute Transgenic plants expressing assembled secretory antibodies
US5202422A (en) 1989-10-27 1993-04-13 The Scripps Research Institute Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins and method of their use
CN1057785A (zh) * 1990-04-16 1992-01-15 哈佛大学校长及研究员协会 合成多聚免疫球蛋白受体，受体-抗体复合物，生产及应用
JPH04169539A (ja) 1990-11-01 1992-06-17 Imuno Japan:Kk 消化器疾患治療・予防剤およびその製造方法

Also Published As

Publication number Publication date
AU4608896A (en) 1996-07-24
US20020159958A1 (en) 2002-10-31
AU722668B2 (en) 2000-08-10
ATE369423T1 (de) 2007-08-15
DE69535557T2 (de) 2008-04-30
CA2208783C (en) 2010-09-28
CN1183802A (zh) 1998-06-03
JPH11504901A (ja) 1999-05-11
EP1911767A2 (en) 2008-04-16
CA2208783A1 (en) 1996-07-11
US6303341B1 (en) 2001-10-16
DE69535557D1 (de) 2007-09-20
EP0807173B1 (en) 2007-08-08
ES2292173T3 (es) 2008-03-01
EP1911767A3 (en) 2008-09-10
WO1996021012A1 (en) 1996-07-11
EP0807173A1 (en) 1997-11-19

Similar Documents

Publication Publication Date Title
DK0807173T3 (da) Fremgangsmåder til fremstilling af immunoglobuliner indeholdende beskyttelsesproteiner i planter og anvendelse deraf
DE69830734D1 (de) Pflanzenwuchserhöhung
EP2169069A3 (en) Phosphatase stress-related proteins and methods of use in plants
BR9104965A (pt) Proteina de tabaco,processo para purificar putrescina n-metiltransferase de um extrato de planta de tabaco,moleculas de dna recombinante,vetor,celula de tabaco transgenica cultivada e planta de tabaco
DK240088A (da) Fremgangsmaade til transformation af et plantecellematerale
DK0699755T3 (da) Fremgangsmåde til opnåelse af modificerede immunglobuliner med reduceret immunogenicitet af variable domæner i et murint antistof, præparater der indeholder disse
AR008286A1 (es) Molecula de acido nucleico aislada, vector, celula, planta transgenica que la incluyen, semilla y celula de dicha planta, polipeptido de resistenciaadquirida codificado por dicha molecula, metodo para producir dicho polipeptido, anticuerpo substancialmente puro que se liga a dicho polipeptido y
Chen et al. Subunit polypeptide composition of fraction I protein from various plant species
BR9707357A (pt) 2,4-Diamino-1,3,5-triazinas processo para a sua preparação e sua aplicação como herbicidas e reguladores do crescimento de plantas
DE59912361D1 (de) 2,4-diamino-1,3,5-triazine, verfahren zur herstellung und verwendung als herbizide und pflanzenwachstumsregulatoren
DK415485A (da) Fremgangsmaade og midler til fremstilling af h-arg-x-z-y-tyr-r
DE3581288D1 (de) Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen.
NO854854L (no) Fremgangsmaate for kvalitativ og kvantitativ forbedring av bladgjoedsling av nytte- og prydplanter i veksthus, paa friland eller ved aakerbruk.
ATE541920T1 (de) Mit stress verbundene proteinphosphatase- polypeptide und verfahren zur verwendung in pflanzen
HUP0003697A2 (hu) A nepovírus-rezisztencia szőlőben
BR8100652A (pt) Processo, composicao agricola e composto reguladores de crescimento de plantas, e processo de preparacao do composto
DK0671121T3 (da) Hybriddyrkningsfremgangsmåder for kulturplanter i familien Brasicaceae
IT8021124A0 (it) Processo per la riproduzione vegetativa di piante con gambi legnosi, in particolare viti.
Argyroudi-Akoyunoglou Polypeptide composition of the pigment-protein complexes of Phaseolus vulgaris thylakoids. Cation-induced disaggregation of oligomeric to monomeric forms correlates with the increase in the ratio F685/F730 in their fluorescence spectra at-196 degrees
Vera et al. A simple procedure to elute proteins from polyacrylamide gels
ATE510016T1 (de) Mit stress assoziierte transkriptionsfaktor- spezifische polypeptide und verfahren zur verwendung in pflanzen
SU858678A1 (ru) Способ отбора винограда на морозоустойчивость
BR9808698A (pt) "processos para a produção de uma planta tolerante a metoxiimino-alfa-(o-tolilóxi)-o-tolilacetato de metila (bas 490f), para a transformação de uma planta e para controlar fungos fitopatogênicos em plantas de cultura tolerantes a metoxiimino-alfa-(o-tolilóxi)-o-tolilacetato de metila (bas 490f) transgênicas cassete de expressão para plantas, cassete de expressão para plantas, usos do cassete de expressão e de uma planta transformada, produção de um polipeptìdeo de ligação a metoxiimino-alfa-(o-tolilóxi)-o-tolilacetato de
NO20012214D0 (no) Fremstilling av en biologisk faktor og frembringelse av et immunologisk fordelaktig miljö ved anvendelse av genetiskforandrede Sertoliceller
RU96120514A (ru) Способ получения апомиктичных гаплоидов льна